23andMe CEO Anne Wojcicki talks with Recode's Kara Swisher in this live interview recorded at the Rock Health Summit in San Francisco. In this episode: (01:30) Elizabeth Warren's heritage and disputed science; (08:10) 23andMe's business and the FDA under Trump; (12:09) The impact of Theranos' implosion; (14:24) The challenges of the consumer market and health analysis; (18:40) Privacy, consent and safety; (24:57) Techlash and being "lumped in"; (29:59) Anti-aging technology; (32:23) Partnering with GSK, solving cold cases and ethics; (37:40) Insurance companies and what Wojcicki wished she knew at the start; (39:20) Diversity and going public Learn more about your ad choices. Visit podcastchoices.com/adchoices
No persons identified in this episode.
This episode hasn't been transcribed yet
Help us prioritize this episode for transcription by upvoting it.
Popular episodes get transcribed faster
Other episodes from Decoder with Nilay Patel
Transcribed and ready to explore now
Amazon’s Panos Panay on the long road to Alexa’s AI overhaul
03 Mar 2025
Decoder with Nilay Patel
Vimeo CEO Philip Moyer is betting on the human touch — and AI
24 Feb 2025
Decoder with Nilay Patel
DeepSeek, Stargate, and the new AI arms race
30 Jan 2025
Decoder with Nilay Patel
How Ciena keeps the internet online, with CEO Gary Smith
27 Jan 2025
Decoder with Nilay Patel
Why CEO Matt Garman is willing to bet AWS on AI
13 Jan 2025
Decoder with Nilay Patel
Answering your biggest Decoder questions
20 Dec 2024
Decoder with Nilay Patel